Report error Found 16 Enz. Inhib. hit(s) with all data for entry = 50037902
TargetIntegrin alpha-V/beta-5(Human)
Johnson & Johnson Pharmaceutical Research and Development
Curated by ChEMBL
Johnson & Johnson Pharmaceutical Research and Development
Curated by ChEMBL
Affinity DataIC50: 0.210nMAssay Description:Binding affinity to Integrin alpha-v-beta-5 receptor by ELISA assayMore data for this Ligand-Target Pair
TargetIntegrin alpha-V/beta-3(Human)
Johnson & Johnson Pharmaceutical Research and Development
Curated by ChEMBL
Johnson & Johnson Pharmaceutical Research and Development
Curated by ChEMBL
Affinity DataIC50: 0.25nMAssay Description:Binding affinity to Integrin alpha-v-beta-3 receptor by ELISA assayMore data for this Ligand-Target Pair
TargetIntegrin alpha-V/beta-3(Human)
Johnson & Johnson Pharmaceutical Research and Development
Curated by ChEMBL
Johnson & Johnson Pharmaceutical Research and Development
Curated by ChEMBL
Affinity DataIC50: 0.380nMAssay Description:Binding affinity to Integrin alpha-v-beta-3 receptor by ELISA assayMore data for this Ligand-Target Pair
TargetIntegrin alpha-V/beta-3(Human)
Johnson & Johnson Pharmaceutical Research and Development
Curated by ChEMBL
Johnson & Johnson Pharmaceutical Research and Development
Curated by ChEMBL
Affinity DataIC50: 0.5nMAssay Description:Binding affinity to Integrin alpha-v-beta-3 receptor by ELISA assayMore data for this Ligand-Target Pair
TargetIntegrin alpha-V/beta-5(Human)
Johnson & Johnson Pharmaceutical Research and Development
Curated by ChEMBL
Johnson & Johnson Pharmaceutical Research and Development
Curated by ChEMBL
Affinity DataIC50: 0.5nMAssay Description:Binding affinity to Integrin alpha-v-beta-5 receptor by ELISA assayMore data for this Ligand-Target Pair
TargetIntegrin alpha-V/beta-5(Human)
Johnson & Johnson Pharmaceutical Research and Development
Curated by ChEMBL
Johnson & Johnson Pharmaceutical Research and Development
Curated by ChEMBL
Affinity DataIC50: 0.680nMAssay Description:Binding affinity to Integrin alpha-v-beta-5 receptor by ELISA assayMore data for this Ligand-Target Pair
TargetIntegrin alpha-V/beta-3(Human)
Johnson & Johnson Pharmaceutical Research and Development
Curated by ChEMBL
Johnson & Johnson Pharmaceutical Research and Development
Curated by ChEMBL
Affinity DataIC50: 0.860nMAssay Description:Binding affinity to Integrin alpha-v-beta-3 receptor by ELISA assayMore data for this Ligand-Target Pair
TargetIntegrin alpha-V/beta-3(Human)
Johnson & Johnson Pharmaceutical Research and Development
Curated by ChEMBL
Johnson & Johnson Pharmaceutical Research and Development
Curated by ChEMBL
Affinity DataIC50: 0.960nMAssay Description:Binding affinity to Integrin alpha-v-beta-3 receptor by ELISA assayMore data for this Ligand-Target Pair
TargetIntegrin alpha-V/beta-5(Human)
Johnson & Johnson Pharmaceutical Research and Development
Curated by ChEMBL
Johnson & Johnson Pharmaceutical Research and Development
Curated by ChEMBL
Affinity DataIC50: 0.960nMAssay Description:Binding affinity to Integrin alpha-v-beta-5 receptor by ELISA assayMore data for this Ligand-Target Pair
TargetIntegrin alpha-V/beta-3(Human)
Johnson & Johnson Pharmaceutical Research and Development
Curated by ChEMBL
Johnson & Johnson Pharmaceutical Research and Development
Curated by ChEMBL
Affinity DataIC50: 1nMAssay Description:Binding affinity to Integrin alpha-v-beta-3 receptor by ELISA assayMore data for this Ligand-Target Pair
TargetIntegrin alpha-V/beta-5(Human)
Johnson & Johnson Pharmaceutical Research and Development
Curated by ChEMBL
Johnson & Johnson Pharmaceutical Research and Development
Curated by ChEMBL
Affinity DataIC50: 1.10nMAssay Description:Binding affinity to Integrin alpha-v-beta-5 receptor by ELISA assayMore data for this Ligand-Target Pair
TargetIntegrin alpha-V/beta-5(Human)
Johnson & Johnson Pharmaceutical Research and Development
Curated by ChEMBL
Johnson & Johnson Pharmaceutical Research and Development
Curated by ChEMBL
Affinity DataIC50: 2.10nMAssay Description:Binding affinity to Integrin alpha-v-beta-5 receptor by ELISA assayMore data for this Ligand-Target Pair
TargetIntegrin alpha-V/beta-3(Human)
Johnson & Johnson Pharmaceutical Research and Development
Curated by ChEMBL
Johnson & Johnson Pharmaceutical Research and Development
Curated by ChEMBL
Affinity DataIC50: 4.40nMAssay Description:Binding affinity to Integrin alpha-v-beta-3 receptor by ELISA assayMore data for this Ligand-Target Pair
TargetIntegrin alpha-V/beta-5(Human)
Johnson & Johnson Pharmaceutical Research and Development
Curated by ChEMBL
Johnson & Johnson Pharmaceutical Research and Development
Curated by ChEMBL
Affinity DataIC50: 11nMAssay Description:Binding affinity to Integrin alpha-v-beta-5 receptor by ELISA assayMore data for this Ligand-Target Pair
TargetIntegrin alpha-V/beta-3(Human)
Johnson & Johnson Pharmaceutical Research and Development
Curated by ChEMBL
Johnson & Johnson Pharmaceutical Research and Development
Curated by ChEMBL
Affinity DataIC50: 14nMAssay Description:Binding affinity to Integrin alpha-v-beta-3 receptor by ELISA assayMore data for this Ligand-Target Pair
TargetIntegrin alpha-V/beta-5(Human)
Johnson & Johnson Pharmaceutical Research and Development
Curated by ChEMBL
Johnson & Johnson Pharmaceutical Research and Development
Curated by ChEMBL
Affinity DataIC50: 15nMAssay Description:Binding affinity to Integrin alpha-v-beta-5 receptor by ELISA assayMore data for this Ligand-Target Pair
